Skip to main content
Equibles

BARCLAYS PLC

Position in RMTI — Rockwell Medical, Inc.

CIK 312069 LONDON, X0
Back to RMTI Full portfolio

Position in RMTI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$114
-$1,303 QoQ
Shares Held
21
-83.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 36 holders
Holding Since
Mar 2020
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RMTI Over Time

Shares Held

Position Value (USD)

Derivatives in RMTI

reported options exposure · as of Jun 30, 2020
CallValue
$4,485
CallShares
21
PutValue
$3,900
PutShares
18

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $487,957,812 across 61 Drug Manufacturers - Specialty & Generic names. RMTI ranks #56 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 2,302,737 $165,474,680
2 NBIX
Neurocrine Biosciences Inc
 324,807 $54,742,970
3 TEVA
Teva Pharmaceutical Industries Ltd
 1,343,554 $45,519,608
4 UTHR
UNITED THERAPEUTICS Corp
 72,010 $39,017,177
5 VTRS
Viatris Inc
 2,437,004 $38,699,622
6 INDV
Indivior Pharmaceuticals, Inc.
 907,024 $37,215,193
7 HIMS
Hims & Hers Health, Inc.
 861,006 $29,851,076
8 ALKS
Alkermes plc.
 219,935 $11,524,592

All Filings in RMTI

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $114 209
2025-03-31 $1,417 1,254
2024-12-31 $58,862 28,854
2024-09-30 $89,821 22,625
2023-09-30 $135 65
2022-09-30 $2 2
2021-09-30 $4,904 8,174
2021-06-30 $14,742 16,201
2021-03-31 $67,582 58,261
2020-12-31 $22,721 22,497
2020-09-30 $34,318 32,073
2020-06-30 $3,900 2,000
2020-06-30 $73,723 37,807
2020-06-30 $4,485 2,300
2020-03-31 $52,670 25,693
2020-03-31 $60,885 29,700
2020-03-31 $7,995 3,900